Completed NA INTERVENTIONAL 2-arm NCT03850106

Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations

Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations During 12-weeks of Supplementation and Concurrent Training

Sponsor: Indus Biotech

Conditions Weakness, Muscle

Interventions Indus810 Placebo

Updated 5 times since 2019 Last updated: Feb 17, 2020 Started: Jul 11, 2018 Primary completion: Mar 15, 2019 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03850106, this NA trial focuses on Weakness, Muscle and remains completed. Sponsored by Indus Biotech, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2020 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Mar 2019 — Mar 2020 [monthly]

Active Not Recruiting NA

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indus Biotech
The Center for Applied Health Sciences, LLC

Data source: The Center for Applied Health Sciences, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stow, United States